FDA Drug Application (022116) for LEXIVA by VIIV HLTHCARE

Back to FDA Applications sponsored by VIIV HLTHCARE

Application Number022116
Product Number001
FormSUSPENSION;ORAL
DosageEQ 50MG BASE/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLEXIVA
Active IngredientFOSAMPRENAVIR CALCIUM

Active IngredientCount
List of drugs with Active Ingredient FOSAMPRENAVIR CALCIUM2


Back to FDA Applications sponsored by VIIV HLTHCARE